DE2645307C2 - - Google Patents

Info

Publication number
DE2645307C2
DE2645307C2 DE2645307A DE2645307A DE2645307C2 DE 2645307 C2 DE2645307 C2 DE 2645307C2 DE 2645307 A DE2645307 A DE 2645307A DE 2645307 A DE2645307 A DE 2645307A DE 2645307 C2 DE2645307 C2 DE 2645307C2
Authority
DE
Germany
Prior art keywords
estriol
estradiol
stage
polyvinylpyrrolidone
lactose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2645307A
Other languages
German (de)
English (en)
Other versions
DE2645307A1 (de
Inventor
Geb. Fixson Ursula Dr. Lachnit-Fixson
Friedmund Prof. Dr. 1000 Berlin De Neumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE19762645307 priority Critical patent/DE2645307A1/de
Priority to NL7709742A priority patent/NL7709742A/xx
Priority to US05/837,323 priority patent/US4145416A/en
Priority to GB40925/77A priority patent/GB1578240A/en
Priority to SE7711102A priority patent/SE7711102L/
Priority to DK438077A priority patent/DK438077A/da
Priority to AU29364/77A priority patent/AU512918B2/en
Priority to BE181485A priority patent/BE859410A/fr
Priority to CA288,196A priority patent/CA1090256A/fr
Priority to ZA00775980A priority patent/ZA775980B/xx
Publication of DE2645307A1 publication Critical patent/DE2645307A1/de
Application granted granted Critical
Publication of DE2645307C2 publication Critical patent/DE2645307C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE19762645307 1976-06-23 1976-10-05 Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen Granted DE2645307A1 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE19762645307 DE2645307A1 (de) 1976-10-05 1976-10-05 Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
NL7709742A NL7709742A (nl) 1976-10-05 1977-09-05 Geneesmiddel voor het behandelen van climacterische verschijnselen, alsmede werkwijze voor het bereiden daarvan.
US05/837,323 US4145416A (en) 1976-06-23 1977-09-27 Novel agents and novel methods for treatment of climacteric disturbances
GB40925/77A GB1578240A (en) 1976-10-05 1977-10-03 Medicament pack and agent for the treatment of climacteric deficiency symptoms
SE7711102A SE7711102L (sv) 1976-10-05 1977-10-04 Nya medel och nya sett att behandla klimakteriska bortfallsymptom
DK438077A DK438077A (da) 1976-10-05 1977-10-04 Midler og metode til behandling af klimateriske mangelsymptomer
AU29364/77A AU512918B2 (en) 1976-10-05 1977-10-05 Treatment of climacteric deficiency systems
BE181485A BE859410A (fr) 1976-10-05 1977-10-05 Nouveaux produits et procedes de traitement de troubles de la menopause
CA288,196A CA1090256A (fr) 1976-10-05 1977-10-05 Medicaments conditionnes pour le traitement des symptomes du climatere
ZA00775980A ZA775980B (en) 1976-10-05 1977-10-05 Medicament pack and agent for the treatment of climacteric deficiency symptoms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762645307 DE2645307A1 (de) 1976-10-05 1976-10-05 Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen

Publications (2)

Publication Number Publication Date
DE2645307A1 DE2645307A1 (de) 1978-04-06
DE2645307C2 true DE2645307C2 (fr) 1988-10-13

Family

ID=5989934

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762645307 Granted DE2645307A1 (de) 1976-06-23 1976-10-05 Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen

Country Status (9)

Country Link
AU (1) AU512918B2 (fr)
BE (1) BE859410A (fr)
CA (1) CA1090256A (fr)
DE (1) DE2645307A1 (fr)
DK (1) DK438077A (fr)
GB (1) GB1578240A (fr)
NL (1) NL7709742A (fr)
SE (1) SE7711102L (fr)
ZA (1) ZA775980B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3029726A1 (de) * 1980-08-06 1982-02-25 Werner Dr.med. 4400 Münster Steinschulte Postkoitale kontrazeptiva mit norgestrel oder levonorgestrel
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
EP0300523B1 (fr) * 1987-07-06 1991-08-14 Akzo N.V. Unité de dosage pharmaceutique pour la prévention ou le traitement des conditions climatères
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
ATE209919T1 (de) * 1987-09-24 2001-12-15 Jencap Res Ltd Oestrogen und progestin enthaltende verhütungspackungen
DE4019670A1 (de) * 1990-06-22 1992-01-09 Erhard Dr Med Roemer Arzneimittel zur behandlung der wechseljahre der frau
DE4104385C1 (fr) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
DE4308406C1 (de) * 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
DE4313926A1 (de) * 1993-04-28 1994-11-03 Jenapharm Gmbh Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (fr) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Utilisation de valvérate d'estradiol ou de 17ß-estradiol combiné à du dienogest pour traiter par voie orale la récupération et/ou l'augmentation de la libido féminine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175468A (en) * 1967-10-19 1969-12-23 Merck Ag E Pharmaceutical Compositions
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
DE2529523C2 (de) * 1975-06-30 1987-04-30 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur Behandlung klimakterischer Ausfallerscheinungen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente

Also Published As

Publication number Publication date
ZA775980B (en) 1978-05-30
CA1090256A (fr) 1980-11-25
AU512918B2 (en) 1980-11-06
DE2645307A1 (de) 1978-04-06
AU2936477A (en) 1979-04-12
SE7711102L (sv) 1978-04-06
DK438077A (da) 1978-04-06
NL7709742A (nl) 1978-04-07
BE859410A (fr) 1978-04-05
GB1578240A (en) 1980-11-05

Similar Documents

Publication Publication Date Title
DE69118494T2 (de) Kontrazeptionsverfahren und Schema
EP0148724B1 (fr) Préparation multiphase séquentielle combinée et son application pour la contraception orale
EP0696454B1 (fr) Préparation pharmaceutique pour la contraception/traitement hormonal de substitution avec des composés oestrogéniques biogéniques
EP0310541B1 (fr) Composés antigestagéniques et anti-oestrogéniques pour le déclenchement de la naissance et pour l'interruption de la grossesse ainsi que pour le traitement des troubles gynécologiques
DE69804918T2 (de) Sehr niedrigdosiertes orales Kontrazeptiv mit weniger Menstruationsblutungen und verzögerter Wirkung
DE3916112C2 (fr)
EP0868188B1 (fr) Kit a usage contraceptif pour mammiferes femelles, constitue d'une combinaison de gestagene et d'oestrogene
DE3855606T2 (de) Verwendung von Melatonin zur Herstellung einer kontrazeptiven Zusammensetzung
DE2645307C2 (fr)
DE69710896T2 (de) Progestogen-anti-progestogen therapien
DE4429397C2 (de) Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE2365103A1 (de) Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
EP1011682A2 (fr) Moyen de contraception hormonale
DE19651000A1 (de) Oxyiminopregnancarbolactone
WO1996005217A1 (fr) Compositions pharmaceutiques comprenant des derives estra-1,3,5(10)-triene
DE2310963A1 (de) Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
DE4411585A1 (de) Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE3022337A1 (de) Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
DE1617686A1 (de) Verfahren zur Anregung von Ovulationszyklen und pharmazeutische Verpackungseinheiten
DE2431704A1 (de) Stufenkombinationspraeparate per kontrazeption
EP0871453A1 (fr) Preparation pharmaceutique combinee de contraception hormonale
DE3438994A1 (de) Antigestagene, glukokortikoide und prostaglandine zur geburtseinleitung oder fuer den schwangerschaftsabbruch
DE3787386T2 (de) In der Behandlung von Östrogeninsuffizienz zu verwendende Zusammensetzung.
DE2431694A1 (de) Kontrzeptionsmittel und kontrazeptivumpackung
DE69027028T2 (de) Als männliches kontrazeptikum verwendbare zusammensetzungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8161 Application of addition to:

Ref document number: 2529523

Country of ref document: DE

Format of ref document f/p: P

8176 Proceedings suspended because of application no:

Ref document number: 2529523

Country of ref document: DE

Format of ref document f/p: P

AF Is addition to no.

Ref country code: DE

Ref document number: 2529523

Format of ref document f/p: P

8178 Suspension cancelled
AF Is addition to no.

Ref country code: DE

Ref document number: 2529523

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition